Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1258, 2009-01, pp. : 1-1
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Co-proxamol suicides down after UK market withdrawal
Reactions Weekly, Vol. 1, Iss. 1403, 2012-01 ,pp. :
Access to resources
Recommend
Co-proxamol to be withdrawn in the UK
Reactions Weekly, Vol. 1, Iss. 1037, 2005-01 ,pp. :
Co-proxamol dangerous in overdose: should access be restricted?
Inpharma, Vol. 1, Iss. 1387, 2003-01 ,pp. :
Positive effects of pholcodine market withdrawal
Reactions Weekly, Vol. 1, Iss. 1343, 2011-01 ,pp. :
Health Canada has announced the withdrawal of marketing authorisation for Prexige [lumiracoxib]
Reactions Weekly, Vol. 1, Iss. 1173, 2007-01 ,pp. :